fentanyl has been researched along with l 365260 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Morphy, R; Rankovic, Z | 1 |
Han, JS; Sun, YH; Zhou, Y | 1 |
Han, JS; Sun, YH; Zhang, ZW; Zhou, Y | 1 |
1 review(s) available for fentanyl and l 365260
Article | Year |
---|---|
Designed multiple ligands. An emerging drug discovery paradigm.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Antihypertensive Agents; Antipsychotic Agents; Chemistry, Pharmaceutical; Dopamine D2 Receptor Antagonists; Drug Design; Humans; Ligands; Metabolic Diseases; Peroxisome Proliferator-Activated Receptors; Receptors, Histamine H1; Selective Serotonin Reuptake Inhibitors | 2005 |
2 other study(ies) available for fentanyl and l 365260
Article | Year |
---|---|
[Potentiation of morphine- and ohmefentanyl-induced analgesia by cholecystokinin receptor antagonists in rat].
Topics: Analgesics; Animals; Benzodiazepinones; Devazepide; Fentanyl; Morphine; Pain Threshold; Phenylurea Compounds; Rats; Rats, Wistar; Receptors, Cholecystokinin; Spinal Cord | 1993 |
Increased release of immunoreactive cholecystokinin octapeptide by morphine and potentiation of mu-opioid analgesia by CCKB receptor antagonist L-365,260 in rat spinal cord.
Topics: Analgesia; Analgesics; Animals; Benzodiazepinones; Devazepide; Dose-Response Relationship, Drug; Fentanyl; Injections, Spinal; Male; Morphine; Naloxone; Nociceptors; Pain Threshold; Phenylurea Compounds; Radioimmunoassay; Rats; Rats, Wistar; Receptors, Cholecystokinin; Receptors, Opioid, mu; Sincalide; Spinal Cord; Subarachnoid Space | 1993 |